Read our blog

What we have to say about tech and biotech...
tax is more exciting than you might think!

Latest posts

Spring Budget 2023: benefits for life sciences and biotech sectors

By CT Team | March 15, 2023
Banner saying 'NEWS'

Research and development (R&D) tax reliefs for SMEs have been refined and will offer some much-needed support for life sciences and tech…

Research and development tax relief ‘single scheme’ consultation launched

By CT Team | February 19, 2023
Chromosomes on black background cancer cells

R&D tax reliefs are very much in the news, due in large part to major changes being made to the schemes by Government. The past decade…

Confluence Tax announces merger with US firm Frazier & Deeter

By CT Team | November 11, 2021

November 11, 2021   Cambridge, UK – Confluence Tax has today announced it is to merge with a US counterpart, Frazier & Deeter, headquartered out of…

R&D tax credits: consultation response 2021

By CT Team | June 3, 2021

The Chancellor of the ExchequerHM Treasury1 Horse Guards RoadLondonSW1A 2HQ June 2, 2021 By email: Dear Chancellor, R&D Tax Reliefs: consultation Thank you for the…

Enterprise Management Incentives (EMI): Confluence Tax response 2021

By CT Team | June 3, 2021

The Chancellor of the ExchequerHM Treasury1 Horse Guards RoadLondon SW1A 2HQ May 24, 2021 Dear Chancellor, Enterprise Management Incentives: call for evidence Thank you for the…

Employment related securities: guide to HMRC filing

By CT Team | May 12, 2021

EMPLOYMENT related securities (ERS) are a common way of incentivising employees within the technology and biotechnology industries. However, issuing shares or share options results in a…

Biotech Employee Equity Survey 2020 results – BEES

By CT Team | December 21, 2020

The Employee Equity Survey was run for biotech companies to enable them to benchmark equity distribution and the size of share option pools..

R&D tax credits: PAYE cap implemented in 2021

By CT Team | November 18, 2020

But there is no need to panic as most companies, including those in biotech and tech, will be minimally affected by the changes.  The PAYE cap legislation around SME…

Budget 2020 tax update for biotech and tech companies

By CT Team | March 16, 2020

THE 2020 Budget was an interesting one, especially for biotech companies. Confluence Tax’s team presented the headline points during the company’s Post-Budget Briefing event held on March 12. The focus was on the main elements that will affect companies from a tax and finance perspective.

Entrepreneurs’ Relief and EMI: letter to HM Treasury

By CT Team | March 3, 2020

Given the speculation in the press regarding the withdrawal of Entrepreneurs’ Relief (ER), I wanted to bring to your attention that Enterprise Management Incentive (EMI) share options rely on ER for their tax efficiency, in enjoying a 10% rate of capital gains tax.